Insider Selling: Phreesia, Inc. (NYSE:PHR) COO Sells 1,892 Shares of Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) COO Evan Roberts sold 1,892 shares of Phreesia stock in a transaction that occurred on Thursday, July 17th. The shares were sold at an average price of $26.89, for a total transaction of $50,875.88. Following the completion of the transaction, the chief operating officer owned 772,915 shares of the company's stock, valued at $20,783,684.35. This trade represents a 0.24% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Phreesia Stock Down 2.2%

Shares of NYSE PHR traded down $0.61 during midday trading on Thursday, hitting $27.09. 420,413 shares of the company's stock were exchanged, compared to its average volume of 577,443. The firm's fifty day simple moving average is $26.58 and its 200-day simple moving average is $26.43. The company has a market cap of $1.61 billion, a PE ratio of -36.60 and a beta of 0.72. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $30.53. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.95 and a quick ratio of 1.95.

Phreesia (NYSE:PHR - Get Free Report) last released its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. The company had revenue of $115.94 million for the quarter, compared to analysts' expectations of $115.00 million. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The firm's revenue for the quarter was up 14.5% on a year-over-year basis. During the same quarter last year, the company earned ($0.05) earnings per share. Research analysts predict that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Wall Street Analyst Weigh In

PHR has been the topic of several analyst reports. DA Davidson upgraded Phreesia to a "strong-buy" rating in a research note on Tuesday. Citigroup reaffirmed a "buy" rating on shares of Phreesia in a research report on Wednesday, May 28th. Truist Financial lifted their price objective on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research note on Thursday, May 29th. Canaccord Genuity Group lowered their price objective on Phreesia from $35.00 to $34.00 and set a "buy" rating for the company in a research report on Thursday, May 29th. Finally, KeyCorp raised their target price on shares of Phreesia from $28.00 to $35.00 and gave the company an "overweight" rating in a report on Monday, July 14th. Eleven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Buy" and an average target price of $32.27.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. grew its stake in Phreesia by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 4,936,515 shares of the company's stock worth $126,177,000 after buying an additional 113,405 shares during the last quarter. Greenhouse Funds LLLP boosted its holdings in shares of Phreesia by 2.9% in the first quarter. Greenhouse Funds LLLP now owns 2,956,910 shares of the company's stock valued at $75,579,000 after acquiring an additional 83,018 shares during the period. Champlain Investment Partners LLC grew its position in shares of Phreesia by 20.0% during the first quarter. Champlain Investment Partners LLC now owns 2,946,489 shares of the company's stock worth $75,312,000 after acquiring an additional 490,340 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Phreesia by 108.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,644,988 shares of the company's stock valued at $67,606,000 after acquiring an additional 1,377,904 shares during the period. Finally, Franklin Resources Inc. raised its position in Phreesia by 0.8% in the 4th quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company's stock valued at $37,982,000 after purchasing an additional 11,986 shares during the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.